Recent Patents on CNS Drug Discovery (Discontinued)
Volume 10, 2 Issues, 2015
ISSN: 2212-3954 (Online)
ISSN: 1574-8898 (Print)
This journal supports open access
ISSN: 2212-3954 (Online)
ISSN: 1574-8898 (Print)
This journal supports open access
Aims & Scope
Recent Patents on CNS Drug Discovery publishes review and research articles, drug clinical trial studies and guest edited thematic issues on recent patents in the field of CNS drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on CNS drug discovery is also included in the journal. The journal is essential reading for all researchers involved in CNS drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to CNS Drug Discovery.
Recent Patents on CNS Drug Discovery (Discontinued)
,Volume 10
-Number 2
Editorial
Meet Our Editorial Board Member
, 10(2): 73 - 74Gjumrakch Aliev
DOI: 10.2174/157488981002160919194411
Meet Our Editorial Board Member
Editorial
Editorial (Thematic Issue: From Old Cannabinoids to Emerging New Synthetic Derivatives with Potential Therapeutic Application in Neurological Disorders)
, 10(2): 75Anna M. Malfitano
DOI: 10.2174/157488981002160919201100
Editorial (Thematic Issue: From Old Cannabinoids to Emerging New Synthetic Derivatives with Potential Therapeutic Application in Neurological Disorders)
Research Article
Peptide Agonists and Antagonists with Potential Application in Neurological Disorders
, 10(2): 76 - 89Anna Russo, Sara La Manna, Giancarlo Morelli, Ettore Novellino and Daniela Marasco
DOI: 10.2174/1574889810666160425121833
Peptide Agonists and Antagonists with Potential Application in Neurological Disorders
Research Article
Endocannabinoid System in Neurological Disorders
, 10(2): 90 - 112Roberta Ranieri, Chiara Laezza, Maurizio Bifulco, Daniela Marasco and Anna M. Malfitano
DOI: 10.2174/1574889810999160719105433
Endocannabinoid System in Neurological Disorders
Research Article
Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple Sclerosis
, 10(2): 113 - 121Anna M. Malfitano, Chiara Laezza, Simona Pisanti, Clementina Manera and Maurizio Bifulco
DOI: 10.2174/1574889810666160421121726
Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple Sclerosis
Research Article
Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases
, 10(2): 122 - 141Andrea Chicca, Chiara Arena and Clementina Manera
DOI: 10.2174/1574889810999160603185126
Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases
Research Article
Synthetic Cannabinoid Receptor Agonists and Antagonists: Implication in CNS Disorders
, 10(2): 142 - 156Clementina Manera, Chiara Arena and Andrea Chicca
DOI: 10.2174/1574889810666160519113853
Synthetic Cannabinoid Receptor Agonists and Antagonists: Implication in CNS Disorders
Research Article
Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders
, 10(2): 157 - 177Roberta Ranieri, Daniela Marasco, Maurizio Bifulco and Anna M. Malfitano
DOI: 10.2174/1574889810666160517123938
Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders
Articles Ahead of Print
There are currently no Articles Ahead of Print available for this journal.
Abstracts Ahead of Print
There are currently no Abstracts Ahead of Print available for this journal.
Published Contents
- Recent Patents on CNS Drug Discovery (Discontinued), Volume 10, 2015
- Recent Patents on CNS Drug Discovery (Discontinued), Volume 9, 2014
- Recent Patents on CNS Drug Discovery (Discontinued), Volume 8, 2013
- Recent Patents on CNS Drug Discovery (Discontinued), Volume 7, 2012
- Recent Patents on CNS Drug Discovery (Discontinued), Volume 6, 2011
- Recent Patents on CNS Drug Discovery (Discontinued), Volume 5, 2010
- Recent Patents on CNS Drug Discovery (Discontinued), Volume 4, 2009
- Recent Patents on CNS Drug Discovery (Discontinued), Volume 3, 2008
- Recent Patents on CNS Drug Discovery (Discontinued), Volume 2, 2007
- Recent Patents on CNS Drug Discovery (Discontinued), Volume 1, 2006
Editor's Choice
Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders
, 2015; 10(2): 157 - 177Roberta Ranieri, Daniela Marasco, Maurizio Bifulco and Anna M. Malfitano
DOI: 10.2174/1574889810666160517123938
Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases
, 2015; 10(2): 122 - 141Andrea Chicca, Chiara Arena and Clementina Manera
DOI: 10.2174/1574889810999160603185126
Neuropharmacological Properties of Withania somnifera - Indian Ginseng: An Overview on Experimental Evidence with Emphasis on Clinical Trials and Patents
, 2015; 10(2): 204 - 215Sarat C. Yenisetti, M. J. Manjunath and Muralidhara
DOI: 10.2174/1574889810666160615014106
Exosome-based strategies for Diagnosis and Therapy
, 2015; 10(1): 10 - 27Lorena Urbanelli, Sandra Buratta, Krizia Sagini, Giuseppina Ferrara, Marco Lanni and Carla Emiliani
DOI: 10.2174/1574889810666150702124059
Drug-Drug Interactions: Antiretroviral Drugs and Recreational Drugs
, 2014; 9(3): 153 - 163Orietta Staltari, Christian Leporini, Benedetto Caroleo, Emilio Russo, Antonio Siniscalchi, Giovambattista De Sarro and Luca Gallelli
DOI: 10.2174/1574889809666141127101623
Possible Physiopathological Effects of the Transglutaminase Activity on the Molecular Mechanisms Responsible for Human Neurodegenerative Diseases
, 2014; 9(2): 76 - 84Martina Iannaccone, Federica Titta, Enrica Serretiello, Marco Monfregola and Vittorio Gentile
DOI: 10.2174/1574889809666141111160124
Migraine Attack Treatment : A Tailor-made Suit, Not One Size Fits All
, 2014; 9(1): 26 - 40Robert Belvis, Natalia Mas and Azahara Aceituno
DOI: 10.2174/1574889809666140307115100
Therapeutic Potential of Cannabinoids in Schizophrenia
, 2014; 9(1): 13 - 25Jana Kucerova, Katarina Tabiova, Filippo Drago and Vincenzo Micale
DOI: 10.2174/1574889809666140307115532
An Ion Channel Chip for Diagnosis and Prognosis of Autoimmune Neurological Disorders
, 2013; 8(3): 171 - 179Franck C. Chatelain, Michel Mazzuca, Marie-Madeleine Larroque, Veronique Rogemond, Jerome Honnorat and Florian Lesage
DOI: 10.2174/15748898113086660004
Modulation of the TRPV1 Channel: Current Clinical Trials and Recent Patents with Focus on Neurological Conditions
, 2013; 8(3): 180 - 204Luciano De Petrocellis and Aniello S. Moriello
DOI: 10.2174/1574889808666131209124012
Open Access Articles
Scientific Prediction and Prophetic Patenting in Drug Discovery
, 2015; 10(1): 34 - 44Stephen H. Curry and Anne M. Schneiderman
Liver Growth Factor as a Tissue Regenerating Factor in Neurodegenerative Diseases
, 2014; 9(3): 173 - 180Rafael Gonzalo-Gobernado, Lucia Calatrava-Ferreras, Juan Perucho, Diana Reimers, MarIa J. Casarejos, Antonio S. Herranz, Adriano Jimenez-Escrig, Juan J. Diaz-Gil and Eulalia Bazan
Analgesic and Antineuropathic Drugs Acting Through Central Cholinergic Mechanisms
, 2011; 6(2): 119 - 140Alessandro Bartolini, Lorenzo Di Cesare Mannelli and Carla Ghelardini
Most Cited Articles
Most Accessed Articles
The Prevention and Treatment of Delirium in Elderly Patients Following Hip Fracture Surgery
, 2015; 10(1): 55-64.Antonio Martocchia, Martina Curto, Fabrizia Comite, Sergio Scaccianoce, Paolo Girardi, Stefano Ferracuti, Ferdinando Nicoletti, Paolo Falaschi and Orthogeriatric Group
DOI: 10.2174/1574889810666150216152624
Exosome-based strategies for Diagnosis and Therapy
, 2015; 10(1): 10-27.Lorena Urbanelli, Sandra Buratta, Krizia Sagini, Giuseppina Ferrara, Marco Lanni and Carla Emiliani
DOI: 10.2174/1574889810666150702124059
Pharmacology and Toxicology of Cannabis Derivatives and Endocannabinoid Agonists
, 2010; 5(1): 46-52.Gilberto Gerra, Amir Zaimovic, Maria L. Gerra, Roberto Ciccocioppo, Andrea Cippitelli, Giovanni Serpelloni and Lorenzo Somaini
DOI: 10.2174/157488910789753521
Anti-Seizure Medications and Estradiol for Neuroprotection in Epilepsy: The 2013 Update
, 2013; 8(1): 24-41.Libor Velisek, Nino Nebieridze, Tamar Chachua and Jana Veliskova
DOI: 10.2174/1574889811308010004
Analgesic and Antineuropathic Drugs Acting Through Central Cholinergic Mechanisms
, 2011; 6(2): 119-140.Alessandro Bartolini, Lorenzo Di Cesare Mannelli and Carla Ghelardini
DOI: 10.2174/157488911795933901
Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives
, 2012; 7(1): 25-40.Simone Tambaro and Marco Bortolato
DOI: 10.2174/157488912798842269
Galanthamine, a Natural Product for the Treatment of Alzheimers Disease
, 2006; 1(1): 105-111.Luis Marco and Maria d. C. Carreiras
DOI: 10.2174/157488906775245246
Individual Triptan Selection in Migraine Attack Therapy
, 2009; 4(1): 70-81.Robert Belvis, Javier Pagonabarraga and Jaime Kulisevsky
DOI: 10.2174/157488909787002555
Antisense Oligonucleotides in the Treatment of Cerebral Gliomas. Review of Concerning Patents
, 2014; 9(1): 2-12.Gerardo Caruso and Maria Caffo
DOI: 10.2174/1574889809666140307113439
Endocannabinoid System in Neurological Disorders
, 2015; 10(2): 90-112.Roberta Ranieri, Chiara Laezza, Maurizio Bifulco, Daniela Marasco and Anna M. Malfitano
DOI: 10.2174/1574889810999160719105433
  |
Editor-in-Chief
Vincenzo Di Marzo
Istituto di Chimica Biomolecolare (I.C.B.)
Consiglio Nazionale delle Ricerche (C.N.R.)
Via Campi Flegrei 34
Pozzuoli, Napoli 80078
Italy
Istituto di Chimica Biomolecolare (I.C.B.)
Consiglio Nazionale delle Ricerche (C.N.R.)
Via Campi Flegrei 34
Pozzuoli, Napoli 80078
Italy
Webmaster Contact: info@benthamscience.net